ArticleInternational journal of clinical oncology2016

Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer.

Kyoichi Kaira et al.PubMed ↗Publisher ↗

No numbers read from the abstract.